These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter. Jeldres C; Lughezzani G; Sun M; Isbarn H; Shariat SF; Budaus L; Lattouf JB; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI J Urol; 2010 Apr; 183(4):1324-9. PubMed ID: 20171666 [TBL] [Abstract][Full Text] [Related]
31. Nephroureterectomy for treating upper urinary tract transitional cell carcinoma: Time to change the treatment paradigm? Brown GA; Busby JE; Wood CG; Pisters LL; Dinney CP; Swanson DA; Grossman HB; Pettaway CA; Munsell MF; Kamat AM; Matin SF BJU Int; 2006 Dec; 98(6):1176-80. PubMed ID: 17125474 [TBL] [Abstract][Full Text] [Related]
32. Re: Maurizio A. Brausi, Mirko Gavioli, Giuseppe De Luca et al. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Eur Urol 2007;52:1414-20. Simone G; Papalia R; Gallucci M Eur Urol; 2008 Aug; 54(2):467; author reply 468. PubMed ID: 18262332 [No Abstract] [Full Text] [Related]
33. Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database. Lughezzani G; Sun M; Perrotte P; Shariat SF; Jeldres C; Budäus L; Latour M; Widmer H; Duclos A; Bénard F; McCormack M; Montorsi F; Karakiewicz PI Urology; 2010 Feb; 75(2):321-7. PubMed ID: 19962727 [TBL] [Abstract][Full Text] [Related]
34. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. Remzi M; Haitel A; Margulis V; Karakiewicz P; Montorsi F; Kikuchi E; Zigeuner R; Weizer A; Bolenz C; Bensalah K; Suardi N; Raman JD; Lotan Y; Waldert M; Ng CK; Fernández M; Koppie TM; Ströbel P; Kabbani W; Murai M; Langner C; Roscigno M; Wheat J; Guo CC; Wood CG; Shariat SF BJU Int; 2009 Feb; 103(3):307-11. PubMed ID: 18990163 [TBL] [Abstract][Full Text] [Related]
35. Long-term outcomes of nephroureterectomy versus endoscopic management for upper tract urothelial carcinoma. Gadzinski AJ; Roberts WW; Faerber GJ; Wolf JS J Urol; 2010 Jun; 183(6):2148-53. PubMed ID: 20399468 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of lymphovascular invasion in transitional cell carcinoma of upper urinary tract. Hong B; Park S; Hong JH; Kim CS; Ro JY; Ahn H Urology; 2005 Apr; 65(4):692-6. PubMed ID: 15833510 [TBL] [Abstract][Full Text] [Related]
37. Laparoscopic radical nephroureterectomy: a multicenter analysis in Japan. Kamihira O; Hattori R; Yamaguchi A; Kawa G; Ogawa O; Habuchi T; Kawauchi A; Uozumi J; Yokoi S; Tsujihata M; Hasui Y; Miyakoda K; Tada H; Ono Y; Naito S Eur Urol; 2009 Jun; 55(6):1397-407. PubMed ID: 19299072 [TBL] [Abstract][Full Text] [Related]
38. Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience. Rouprêt M; Hupertan V; Sanderson KM; Harmon JD; Cathelineau X; Barret E; Vallancien G; Rozet F Urology; 2007 Apr; 69(4):656-61. PubMed ID: 17445646 [TBL] [Abstract][Full Text] [Related]
39. Retroperitoneal lymph node dissection (RPLD) in conjunction with nephroureterectomy in the treatment of infiltrative transitional cell carcinoma (TCC) of the upper urinary tract: impact on survival. Brausi MA; Gavioli M; De Luca G; Verrini G; Peracchia G; Simonini G; Viola M Eur Urol; 2007 Nov; 52(5):1414-8. PubMed ID: 17507148 [TBL] [Abstract][Full Text] [Related]
40. Nephroureterectomy: rationale in the management of transitional cell carcinoma of the upper urinary tract. Cummings KB Urol Clin North Am; 1980 Oct; 7(3):569-78. PubMed ID: 7456169 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]